Live feed
Filing
SC 13D/A
SC 13D/A0000919574-18-000694·LANSDOWNE PARTNERS
Schedule 13D ownership disclosure
Summit Therapeutics plc
Security class unavailable · CUSIP: 86627R102
Event date: 2017-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 25.9100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-18-000694
- Form type
- SC 13D/A
- Filer
- LANSDOWNE PARTNERS
- CIK
- CIK 1608485
- Filed
- Jan 30, 2018
- Reporting period
- Dec 29, 2017
- Description
- Schedule 13D beneficial ownership